Exam Room (IMAGE) MediaSource Caption Dr. Sara Hurvitz (left) led a study at UCLA Jonsson Comprehensive Cancer Center that found adding a drug that inhibits the growth of cancer cells to standard hormone therapy greatly improved overall survival in women with advanced-stage breast cancer. Credit UCLA Jonsson Comprehensive Cancer Center Usage Restrictions All multimedia is available for free and unrestricted media use with courtesy to UCLA Jonsson Comprehensive Cancer Center. License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.